Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

Recruiting now · Phase 4

Conditions studied: Leukaemia (Acute), Acute Lymphoblastic Leukemia

In brief

This current study will implement a proposed whole program of monitoring and prevention acute hepatic injury during the time of induction chemotherapy in children and adolescent with ALL.

Key facts

Study ID

NCT06918054

Run by

Ain Shams University

People needed

42

Starts

2023-11-17

Expected to finish

2025-08-01

Last updated by the study team

2025-04-09

Who can join

Age: 2 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Children and adolescents aged from 2 to 18 years newly diagnosed with acute lymphoblastic leukemia during induction phase of chemotherapy treated at Ain Shams

You may not qualify if…

• Known chronic liver disease.

Where it is running

• Ain Shams University — Cairo, Egypt (enrolling)
• Faculty of Medicine Ain Shams Research Institute- Clinical Research Center (MASRI-CRC) — Cairo, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.